FerreiraMJ, IrigoyenMC, Consolim-ColomboF, SaraivaJFK, AngelisKD. Physically Active Lifestyle as an Approach to Confronting COVID-19. Arq. Bras. Cardiol. 2020;114(4):601-2.
Ferreira,Maycon Junior; Irigoyen,Maria Cláudia; Consolim-Colombo,Fernanda; Saraiva,José Francisco Kerr; Angelis,Kátia De. Physically Active Lifestyle as an Approach to Confronting COVID-19. Arq. Bras. Cardiol., v. 114, n. 4, p. 601-602, Apr. 2020.
Ferreira,M.J., Irigoyen,M.C., Consolim-Colombo,F., Saraiva,J.F.K., & Angelis,K.D. (2020). Physically Active Lifestyle as an Approach to Confronting COVID-19. Arq. Bras. Cardiol.,114(4), 601-602.
Ferreira,Maycon Junior and Irigoyen,Maria Cláudia and Consolim-Colombo,Fernanda and Saraiva,José Francisco Kerr and Angelis,Kátia De. Physically Active Lifestyle as an Approach to Confronting COVID-19. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 4, [cited 2025-09-06], pp.601-602. Available from: <https://abccardiol.org/en/article/physically-active-lifestyle-as-an-approach-to-confronting-covid-19/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.